Yoshinobu Kanda
#86,232
Most Influential Person Now
Researcher
Yoshinobu Kanda's AcademicInfluence.com Rankings
Yoshinobu Kandacomputer-science Degrees
Computer Science
#2891
World Rank
#3027
Historical Rank
Computational Linguistics
#72
World Rank
#74
Historical Rank
Machine Learning
#226
World Rank
#229
Historical Rank
Artificial Intelligence
#387
World Rank
#394
Historical Rank
Download Badge
Computer Science
Yoshinobu Kanda's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Yoshinobu Kanda Influential?
(Suggest an Edit or Addition)Yoshinobu Kanda's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Investigation of the freely available easy-to-use software ‘EZR' for medical statistics (2012) (10043)
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic‐Cell Transplantation (2017) (643)
- Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1→3)-β-d-Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders (2004) (290)
- Mouse Jagged1 Physically Interacts with Notch2 and Other Notch Receptors (1999) (259)
- Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. (2001) (237)
- Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. (2017) (226)
- Elevated B-type natriuretic peptide levels after anthracycline administration. (1998) (181)
- Binding of Delta1, Jagged1, and Jagged2 to Notch2 Rapidly Induces Cleavage, Nuclear Translocation, and Hyperphosphorylation of Notch2 (2000) (174)
- Prophylactic action of oral fluconazole against fungal infection in neutropenic patients (2000) (155)
- Real-Time Automated PCR for Early Diagnosis and Monitoring of Cytomegalovirus Infection after Bone Marrow Transplantation (2000) (149)
- Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). (2003) (138)
- Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer‐cell neoplasms (2005) (137)
- FDG-PET in T-cell and NK-cell neoplasms. (2007) (128)
- Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation (2004) (124)
- Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy‐based study involving 720 patients with haematological malignancy (2002) (116)
- Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients. (2000) (112)
- Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation (2001) (110)
- Early Immune Reaction after Reduced-Intensity Cord-Blood Transplantation for Adult Patients (2005) (106)
- Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma (2001) (103)
- Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome (2005) (100)
- Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan (2001) (99)
- A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study. (2006) (95)
- Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia. (2018) (94)
- Allogeneic haematopoietic stem cell transplantation for the treatment of adult T‐cell leukaemia/lymphoma (2003) (89)
- Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan level (2001) (82)
- Long‐term ultra‐low‐dose acyclovir against varicella‐zoster virus reactivation after allogeneic hematopoietic stem cell transplantation (2008) (79)
- Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation. (1995) (78)
- Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme‐linked immunosorbent assay (1999) (75)
- Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma. (2002) (71)
- TT virus in bone marrow transplant recipients. (1999) (71)
- Host-Residual Invariant NK T Cells Attenuate Graft-versus-Host Immunity1 (2005) (70)
- Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia (2013) (69)
- Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. (2007) (69)
- Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients (2005) (67)
- Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease. (2017) (65)
- Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease (1998) (64)
- False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. (2007) (64)
- Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. (2005) (63)
- Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results (2018) (63)
- Chest computed tomography of late invasive aspergillosis after allogeneic hematopoietic stem cell transplantation. (2005) (62)
- In Vivo Alemtuzumab Enables Haploidentical Human Leukocyte Antigen-Mismatched Hematopoietic Stem-Cell Transplantation Without Ex Vivo Graft Manipulation (2005) (61)
- Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation. (2008) (61)
- Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation. (2002) (60)
- Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan (2004) (58)
- Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation (2011) (58)
- Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials. (2014) (55)
- NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies (2009) (55)
- Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials. (2014) (55)
- Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. (2014) (54)
- The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia (2000) (53)
- Secondary solid tumors after allogeneic hematopoietic SCT in Japan (2012) (53)
- Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan (2005) (53)
- Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. (2009) (52)
- Risk factors for pre‐ and post‐engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation (2015) (52)
- Risk factors for pre‐ and post‐engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation (2015) (52)
- Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program. (2007) (52)
- Decreased incidence of acute graft‐versus‐host disease by continuous infusion of cyclosporine with a higher target blood level (2008) (52)
- Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases. (2007) (52)
- The Role of PGE2 in the Differentiation of Dendritic Cells: How Do Dendritic Cells Influence T‐Cell Polarization and Chemokine Receptor Expression? (2002) (51)
- Influence of various hemodialysis membranes on the plasma (1-->3)-beta-D-glucan level. (2001) (51)
- Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate (2004) (50)
- Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease (2017) (49)
- Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria. (2001) (49)
- Reverse Seroconversion of Hepatitis B Virus after Hematopoietic Stem Cell Transplantation (2002) (49)
- The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy‐based retrospective study of 48 patients (2002) (48)
- A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission. (2011) (48)
- Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation (2002) (48)
- Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation. (2013) (47)
- Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms (2007) (47)
- Predictors for severe cardiac complications after hematopoietic stem cell transplantation (2004) (47)
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients (2006) (47)
- Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis. (2002) (47)
- Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease (2005) (47)
- THYROID FUNCTION AFTER BONE MARROW TRANSPLANTATION: POSSIBLE ASSOCIATION BETWEEN IMMUNE-MEDIATED THYROTOXICOSIS AND HYPOTHYROIDISM (2001) (47)
- Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation (2003) (46)
- Evaluation of cytomegalovirus‐specific T‐cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon‐γ‐enzyme‐linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T‐cell epitope (2005) (46)
- Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment (2013) (45)
- Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response (2018) (45)
- Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen. (2004) (45)
- Recovery of Vα24+ NKT cells after hematopoietic stem cell transplantation (2004) (45)
- Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study. (2012) (44)
- Triple synergism of human T-lymphotropic virus type 1-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells (1997) (44)
- Graft failure following reduced‐intensity cord blood transplantation for adult patients (2006) (43)
- Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution (2003) (42)
- Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan. (2015) (42)
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry (2010) (41)
- Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation. (2012) (41)
- Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia (1996) (41)
- Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation (2008) (40)
- Aspergillus tracheobronchitis after allogeneic bone marrow transplantation (1999) (40)
- Bronchiolitis obliterans organizing pneumonia after syngeneic bone marrow transplantation for acute lymphoblastic leukemia (1997) (40)
- A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT (2010) (39)
- False-positive results of Aspergillus enzyme-linked immunosorbent assay in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation (2001) (39)
- Early relapse of JAK2 V617F‐positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation (2007) (38)
- Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission (2013) (37)
- Early diagnosis of central nervous system aspergillosis with combination use of cerebral diffusion-weighted echo-planar magnetic resonance image and polymerase chain reaction of cerebrospinal fluid. (1999) (37)
- Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation. (2019) (37)
- No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes (1997) (37)
- High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation (2005) (37)
- Impact of human leucocyte antigen mismatch on graft‐versus‐host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors (2005) (36)
- Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial (2020) (36)
- Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program. (2004) (36)
- Vα24+ natural killer T cells are markedly decreased in atopic dermatitis patients (2003) (36)
- Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations. (2016) (36)
- Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluid (2003) (35)
- Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia. (1999) (35)
- Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients. (2011) (35)
- Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. (2014) (35)
- Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. (2014) (35)
- Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation (2005) (34)
- PBSC collection from family donors in Japan: a prospective survey (2014) (34)
- A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor (2011) (34)
- Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA‐matched sibling donor (2006) (34)
- Plasma concentration of itraconazole in patients receiving chemotherapy for hematological malignancies: the effect of famotidine on the absorption of itraconazole (1998) (34)
- Preservation of ovarian function by ovarian shielding when undergoing total body irradiation for hematopoietic stem cell transplantation: a report of two successful cases (2006) (33)
- Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy. (2014) (33)
- Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplantation Recipients 50 Years or Older. (2017) (33)
- Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplantation Recipients 50 Years or Older. (2017) (33)
- In vivo T‐cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA‐mismatched haploidentical transplantation (2013) (33)
- Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched‐pair analysis (2015) (33)
- Acute adrenal failure associated with fluconazole after administration of high‐dose cyclophosphamide (2001) (32)
- Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients. (2007) (32)
- Use of hydroxy‐methyl‐glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies (2006) (32)
- Low‐dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation (2013) (32)
- Low‐dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation (2013) (32)
- Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction (2013) (32)
- Novel Anticytomegalovirus Activity of Immunosuppressant Mizoribine and Its Synergism with Ganciclovir (2010) (32)
- Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation (2005) (31)
- Retrospective evaluation of the area over the neutrophil curve index to predict early infection in hematopoietic stem cell transplantation recipients. (2010) (31)
- A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease. (2005) (31)
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group (2011) (31)
- Executive Summary of Japanese Domestic Guidelines for Management of Deep-seated Mycosis 2014. (2016) (31)
- Frequent false‐positive results of Aspergillus latex agglutination test (1999) (31)
- [Statistical analysis using freely-available "EZR (Easy R)" software]. (2015) (30)
- Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor. (2005) (30)
- Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation (2015) (30)
- Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation (2015) (30)
- Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation. (2016) (29)
- Graft-versus-Tumor Effect Against Advanced Pancreatic Cancer after Allogeneic Reduced-Intensity Stem Cell Transplantation (2005) (29)
- Pyogenic Granuloma of the Tongue Early after Allogeneic Bone Marrow Transplantation for Multiple Myeloma (2000) (29)
- Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years (2005) (29)
- Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation. (2016) (29)
- The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia. (2007) (29)
- Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation. (2015) (29)
- Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience (2019) (29)
- Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells (2007) (28)
- Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation. (1998) (28)
- Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan (2016) (28)
- Increased incidence of acute graft-versus-host disease with the continuous infusion of cyclosporine A compared to twice-daily infusion (2004) (28)
- Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia (2021) (28)
- Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT (2013) (27)
- ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern (2016) (27)
- Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT (2013) (27)
- Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation. (2019) (27)
- Serum Levels of Soluble Interleukin-2 Receptor after Bone Marrow Transplantation: A True Marker of Acute Graft-Versus-Host Disease (2000) (26)
- Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy (2015) (26)
- Clinical outcome in patients with small intestinal non-Hodgkin lymphoma (2009) (26)
- Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma (2011) (26)
- Extramedullary relapse in the so-called ‘sanctuary’ sites for chemotherapy after donor lymphocyte infusion (2000) (26)
- Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group (2014) (26)
- A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation (2016) (25)
- High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma (2003) (25)
- Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan. (2001) (25)
- Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation (2003) (25)
- Improvement of early mortality in single‐unit cord blood transplantation for Japanese adults from 1998 to 2017 (2019) (25)
- The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia (2010) (24)
- Primary cutaneous aspergillosis caused by Aspergillus ustus following reduced-intensity stem cell transplantation (2002) (24)
- Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. (2019) (24)
- Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin (2002) (23)
- Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma. (2010) (23)
- Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation (2010) (23)
- One‐year low‐dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group (2010) (23)
- Biased usage of BV gene families of T‐cell receptors of WT1 (Wilms’ tumor gene)‐specific CD8+ T cells in patients with myeloid malignancies (2010) (23)
- Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin. (2001) (23)
- Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia (2010) (23)
- Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma (2009) (22)
- Impact of HLA Allele Mismatch at HLA-A, -B, -C, and -DRB1 in Single Cord Blood Transplantation. (2019) (22)
- Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysis (2012) (22)
- Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome‐positive acute lymphoblastic leukemia (2019) (22)
- Recovery of Valpha24+ NKT cells after hematopoietic stem cell transplantation. (2004) (22)
- Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairment. (2006) (22)
- Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies (2018) (22)
- Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant recipient (2003) (21)
- Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease. (2018) (21)
- Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors. (2019) (21)
- Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation (1998) (21)
- Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation (2010) (21)
- Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation (2017) (21)
- Ovarian shielding allows ovarian recovery and normal birth in female hematopoietic SCT recipients undergoing TBI (2008) (21)
- Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation (2017) (21)
- Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement (2018) (21)
- Impact of graft‐versus‐host disease in reduced‐intensity stem cell transplantation (RIST) for patients with haematological malignancies (2003) (20)
- Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide (2017) (20)
- Case Report: Persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes (2008) (19)
- Prognostic Significance of Serum Soluble Interleukin-2 Receptor Level in Non-Hodgkin's Lymphoma: A Single Center Study in Japan (2000) (19)
- Evaluation of the Validity of Preemptive Therapy against Cytomegalovirus Disease Based on Antigenemia Assay with a Cutoff of 20 Positive Cells per Two Slides (2013) (19)
- Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab (2008) (19)
- Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. (2017) (19)
- Evaluation of the Validity of Preemptive Therapy against Cytomegalovirus Disease Based on Antigenemia Assay with a Cutoff of 20 Positive Cells per Two Slides (2013) (19)
- Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life. (2019) (19)
- Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia (2017) (19)
- Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia (2017) (19)
- Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes (2020) (19)
- A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia. (2016) (19)
- Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on the outcome of unrelated bone marrow transplantation. (2014) (19)
- Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation (2014) (18)
- Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation (2014) (18)
- Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial) (2018) (18)
- Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies. (2013) (18)
- Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure (2000) (18)
- Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34‐positive cells or total nucleated cells? (2018) (18)
- The diagnostic value of kappa/lambda ratios determined by flow cytometric analysis of biopsy specimens in B-cell lymphoma. (2002) (18)
- Herpes simplex encephalitis and subsequent cytomegalovirus encephalitis after chemoradiotherapy for central nervous system lymphoma: a case report and literature review (2008) (18)
- Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: Does body weight matter? (2008) (18)
- Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma in Sjögren's syndrome showing only the LIP pattern radiologically. (2012) (17)
- Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft‐versus‐host disease and survival outcome (2018) (17)
- Successful allogeneic blood stem cell transplantation for aplastic anemia in a patient with renal insufficiency requiring dialysis (2002) (17)
- Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft‐versus‐host disease and survival outcome (2018) (17)
- Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma (2015) (17)
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd (2011) (17)
- Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan (2016) (17)
- Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG‐PET scan before transplantation (2008) (17)
- Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia (2009) (17)
- Overexpression of the MEN/ELL Protein, an RNA Polymerase II Elongation Factor, Results in Transformation of Rat1 Cells with Dependence on the Lysine-rich Region* (1998) (16)
- Fulminant hepatic failure caused by adenovirus infection mimicking peliosis hepatitis on abdominal computed tomography images after allogeneic hematopoietic stem cell transplantation. (2012) (16)
- Fulminant hepatic failure caused by adenovirus infection mimicking peliosis hepatitis on abdominal computed tomography images after allogeneic hematopoietic stem cell transplantation. (2012) (16)
- Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey (2018) (16)
- Long-Term Persistence of Limited HTLV-I Tax-specific Cytotoxic T Cell Clones in a Patient with Adult T Cell Leukemia/Lymphoma after Allogeneic Stem Cell Transplantation (2012) (16)
- Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation (2016) (16)
- Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation (2018) (16)
- Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO‐incompatible donor (2002) (16)
- A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis. (2016) (16)
- Outcome after first relapse in adult patients with Philadelphia chromosome‐negative acute lymphoblastic leukaemia (2013) (16)
- High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation. (2016) (16)
- Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial (2017) (16)
- Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation (2012) (16)
- Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations (2016) (16)
- Long-Term Persistence of Limited HTLV-I Tax-specific Cytotoxic T Cell Clones in a Patient with Adult T Cell Leukemia/Lymphoma after Allogeneic Stem Cell Transplantation (2012) (16)
- High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation. (2016) (16)
- A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies (2011) (16)
- Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation (2007) (16)
- Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation (2018) (16)
- Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement. (2019) (15)
- Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission. (2021) (15)
- Fludarabine, cyclophosphamide, anti‐thymocyteglobulin, and low‐dose total body irradiation conditioning enables 1‐HLA‐locus‐mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function (2009) (15)
- Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases. (2006) (15)
- Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia? (2011) (15)
- Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab (2005) (15)
- Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy (2017) (15)
- Serum levels of fluconazole in patients after cytotoxic chemotherapy for hematological malignancy (2001) (15)
- Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan (2007) (15)
- Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients. (2017) (15)
- Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia. (2020) (15)
- Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy (2017) (15)
- Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients. (2017) (15)
- Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients (2015) (14)
- Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia (2019) (14)
- V alpha 24+ natural killer T cells are markedly decreased in atopic dermatitis patients. (2003) (14)
- Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents (2019) (14)
- Reduced‐intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first‐donor origin (2003) (14)
- Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan (2018) (14)
- Simple prognostic model for patients with multiple myeloma: a single-center study in Japan (2001) (14)
- Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients (2015) (14)
- Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation (2020) (14)
- Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation (2001) (14)
- Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents (2019) (14)
- Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR (2018) (14)
- Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial (2018) (14)
- Aspergillus endocarditis in a leukemia patient diagnosed by a PCR assay. (1997) (14)
- Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups. (2019) (14)
- Clinical Value of Serial Measurement of Serum C-Reactive Protein Level in Neutropenic Patients (2001) (14)
- Long-Term Ultra-Low-Dose Acyclovir Against Varicella-Zoster Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation. (2007) (13)
- Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation (2018) (13)
- Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. (2017) (13)
- Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT (2014) (13)
- Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT (2014) (13)
- Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001–2005 using the Japan Adult Leukemia Study Group AML201 protocols (2018) (13)
- Multicenter phase II trial of vitamin K(2) monotherapy and vitamin K(2) plus 1alpha-hydroxyvitamin D(3) combination therapy for low-risk myelodysplastic syndromes. (2010) (13)
- Feasibility of acute physiology and chronic health evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation (2003) (13)
- Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades (2018) (13)
- Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding (2016) (13)
- A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia (2014) (13)
- Primary cutaneous anaplastic large cell lymphoma with leg involvement: A case report and review of 11 cases (2011) (13)
- The safety and efficacy of acute graft‐versus‐host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL (2013) (13)
- Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding (2016) (13)
- Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy (2015) (13)
- Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. (2017) (13)
- A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia (2014) (13)
- Prognostic Factors in Elderly Patients with Acute Myelogenous Leukemia: A Single Center Study in Japan (2002) (13)
- False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation. (2015) (13)
- Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation (2016) (13)
- False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation. (2015) (13)
- Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation (2016) (13)
- Association between serum high-molecular-weight adiponectin level and the severity of chronic graft-versus-host disease in allogeneic stem cell transplantation recipients. (2011) (13)
- Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT (2010) (13)
- The safety and efficacy of acute graft‐versus‐host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL (2013) (13)
- HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin) (2017) (12)
- Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT (2014) (12)
- Development of a unique T-cell receptor gene-transferred Tax-redirected T-cell immunotherapy for adult T-cell leukemia. (2020) (12)
- D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial. (2020) (12)
- Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation. (2017) (12)
- The Role of Allogeneic Transplantation for Multiple Myeloma in the Era of Novel Agents: A Study from the Japanese Society of Myeloma. (2018) (12)
- HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin) (2017) (12)
- Unilateral papilledema after bone marrow transplantation (1999) (12)
- Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan (2018) (12)
- [The effects of indomethacin spray on the pain of stomatitis in the patients for hematopoietic stem cell transplantation]. (2003) (12)
- Pneumocystis Carinii Pneumonia with an Atypical Granulomatous Response in a Patient with Chronic Lymphocytic Leukemia (2001) (12)
- The Role of Allogeneic Transplantation for Multiple Myeloma in the Era of Novel Agents: A Study from the Japanese Society of Myeloma. (2018) (12)
- Spontaneous Remission in Acute Type Adult T-Cell Leukemia/Lymphoma (2000) (12)
- Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen. (2017) (12)
- Development of a unique T-cell receptor gene-transferred Tax-redirected T-cell immunotherapy for adult T-cell leukemia. (2020) (12)
- Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission (2016) (12)
- Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors (2015) (11)
- Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplant (2012) (11)
- D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine (2014) (11)
- Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse (2018) (11)
- Management of infection in patients with acute leukemia during chemotherapy in Japan: questionnaire analysis by the Japan Adult Leukemia Study Group (2009) (11)
- Cord Blood Transplantation for Multiple Myeloma: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation. (2015) (11)
- B cell lymphoma-associated hemophagocytic syndrome after PBSCT (1998) (11)
- Smoking and alcohol and subsequent risk of myelodysplastic syndromes in Japan: the Japan Public Health Centre‐based Prospective Study (2017) (11)
- Prediction of infectious events by high-sensitivity C-reactive protein level before undergoing chemotherapy for acute myeloid leukaemia (2010) (11)
- Cord Blood Transplantation for Multiple Myeloma: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation. (2015) (11)
- A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation (2020) (11)
- Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia (2017) (11)
- Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma (2017) (11)
- A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donors. (2006) (11)
- D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine (2014) (11)
- False-positive elevation of 1,3-beta-D-glucan caused by continuous administration of penicillin G. (2018) (10)
- Haploidentical transplantation using low‐dose alemtuzumab: Comparison with haploidentical transplantation using low‐dose thymoglobulin (2019) (10)
- Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. (2014) (10)
- Effect of cytomegalovirus reactivation with or without acute graft-versus-host disease on the risk of nonrelapse mortality. (2020) (10)
- Haploidentical transplantation using low‐dose alemtuzumab: Comparison with haploidentical transplantation using low‐dose thymoglobulin (2019) (10)
- Evaluation of thrombotic events in patients with immune thrombocytopenia (2019) (10)
- Treatment of Deep Vein Thrombosis Using Temporary Vena Caval Filters after Allogeneic Bone Marrow Transplantation (2000) (10)
- Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS) (2012) (10)
- Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. (2014) (10)
- Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) (2018) (10)
- Increased serum soluble Fas ligand associated with recurrent B-cell non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation. (1999) (10)
- Retrospective assessment of secondary prophylaxis for invasive aspergillosis in neutropenic hematology patients and identification of risk factors for relapse of fungal disease (2013) (10)
- Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group (2017) (10)
- Ischemic colitis as a manifestation of thrombotic microangiopathy following bone marrow transplantation. (2003) (10)
- Immune recovery after autologous PBSC transplantation without in vitro graft manipulation for refractory systemic lupus erythematosus (2011) (10)
- TT virus in frequently transfused patients. (1999) (10)
- Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT (2020) (10)
- Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. (2019) (9)
- Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis (2019) (9)
- Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts. (2014) (9)
- A retrospective analysis of computed tomography findings in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation. (2015) (9)
- Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemia (2018) (9)
- Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies. (2013) (9)
- Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese survey (2008) (9)
- A retrospective analysis of computed tomography findings in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation. (2015) (9)
- Hyperacute graft‐versus‐host disease and NKT cells (2000) (9)
- Limited efficacy of lamivudine against hepatitis B virus infection in allogeneic hematopoietic stem cell transplant recipients. (2002) (9)
- Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation (2015) (9)
- Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts. (2014) (9)
- Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program (2021) (9)
- Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies. (2013) (9)
- Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation (2015) (9)
- Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency (2013) (9)
- Time-Varying Effects of Graft Type on Outcomes for Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. (2020) (9)
- Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation (2020) (8)
- Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP (2018) (8)
- Recurrence of monoclonal gammopathy associated with donor-derived myelodysplastic syndrome after cord blood stem cell transplantation. (2011) (8)
- Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, l-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL (2015) (8)
- Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma (2015) (8)
- Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation (2014) (8)
- Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, l-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL (2015) (8)
- Associations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome (2018) (8)
- ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation (2019) (8)
- Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP (2017) (8)
- Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study. (2016) (8)
- Disseminated adenovirus disease by multiple adenovirus serotypes following allogeneic hematopoietic stem cell transplantation. (2008) (8)
- Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation (2014) (8)
- Long-term sustained mixed chimerism after allogeneic stem cell transplantation in a patient with severe aplastic anemia. (2007) (8)
- Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma (2015) (8)
- Malignant hyperthermia induced by general anesthesia for bone marrow harvesting (1997) (8)
- Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation (2013) (8)
- Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis (2020) (8)
- A single high‐resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low‐resolution HLA mismatch (2015) (7)
- Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine (2021) (7)
- Reverse seroconversion of hepatitis B virus after allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease (2009) (7)
- Association between the kinetics of cytomegalovirus reactivation evaluated in terms of the area under the curve of cytomegalovirus antigenemia and invasive mold infection during the post‐engraftment phase after allogeneic hematopoietic stem cell transplantation (2020) (7)
- Association between the kinetics of cytomegalovirus reactivation evaluated in terms of the area under the curve of cytomegalovirus antigenemia and invasive mold infection during the post‐engraftment phase after allogeneic hematopoietic stem cell transplantation (2020) (7)
- Coffee and Green Tea Consumption and Subsequent Risk of Malignant Lymphoma and Multiple Myeloma in Japan: The Japan Public Health Center-based Prospective Study (2017) (7)
- Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type (2021) (7)
- Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia (2019) (7)
- Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation (2019) (7)
- HIV Status (2020) (7)
- Outcome of gastrointestinal graft-versus-host disease according to the treatment response (2018) (7)
- Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma (2015) (7)
- Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan (2018) (7)
- L‐index as a novel index to evaluate both the intensity and duration of lymphopenia after allogeneic hematopoietic stem cell transplantation (2012) (7)
- Efficacy and safety of tazobactam/piperacillin as an empirical treatment for the patients of adult and child with febrile neutropenia in Japan. (2015) (7)
- Outcome of gastrointestinal graft-versus-host disease according to the treatment response (2018) (7)
- Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation (2019) (7)
- Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation (2019) (7)
- Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1 (2022) (7)
- Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia. (2001) (7)
- Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling (2016) (7)
- Impact of graft‐versus‐host disease and graft‐versus‐leukemia effect based on minimal residual disease in Philadelphia chromosome‐positive acute lymphoblastic leukemia (2020) (6)
- Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective Analysis (2019) (6)
- Should busulfan-containing regimen be avoided for young female patients undergoing hematopoietic stem cell transplantation? (2009) (6)
- Simultaneous appearance of central nervous system relapse and subarachnoid hemorrhage during the treatment for acute promyelocytic leukemia (2008) (6)
- Hierarchical Linear Modeling (HLM) (2020) (6)
- Clinical association between thyroid disease and immune thrombocytopenia (2020) (6)
- A case of adult Langerhans cell histiocytosis showing successfully regenerated osseous tissue of the skull after chemotherapy (2008) (6)
- Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission (2021) (6)
- Pharmacokinetics of alemtuzumab after haploidentical HLA‐mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab with or without CD52‐positive malignancies (2006) (6)
- Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript. (2016) (6)
- Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success. (2018) (6)
- Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation (2012) (6)
- Induction chemotherapy followed by allogeneic HCT versus upfront allogeneic HCT for advanced myelodysplastic syndrome: A propensity score matched analysis (2018) (6)
- Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success. (2018) (6)
- A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-host disease by National Institutes of Health Criteria in a Japanese cohort. (2019) (6)
- Detection of T315I using digital PCR in allogeneic transplant recipients with Ph-positive ALL in the dasatinib era. (2020) (6)
- Detection of T315I using digital PCR in allogeneic transplant recipients with Ph-positive ALL in the dasatinib era. (2020) (6)
- Updated clinical outcomes of hematopoietic stem cell transplantation using myeloablative total body irradiation with ovarian shielding to preserve fertility. (2019) (6)
- Reconstitution of HLA-A*2402-Restricted Cytomegalovirus-Specific T-Cells Following Stem Cell Transplantation (2004) (6)
- Daratumumab in first-line is cost-effective in transplant-eligible newly diagnosed myeloma patients. (2022) (6)
- A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients (2017) (6)
- A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients (2017) (6)
- Clinical Significance of Peripheral Blood Erythroblastosis after Hematopoietic Stem Cell Transplantation (2004) (6)
- BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient. (2019) (6)
- Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group (2020) (6)
- Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302) (2018) (6)
- Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation (2011) (6)
- Fatal cardiac toxicity in two patients receiving same-day administration of cyclophosphamide and cytarabine as conditioning for hematopoietic stem cell transplantation. (2001) (6)
- Serial serum thrombopoietin levels in a pregnant woman with essential thrombocythaemia (1999) (6)
- Updated clinical outcomes of hematopoietic stem cell transplantation using myeloablative total body irradiation with ovarian shielding to preserve fertility. (2019) (6)
- Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation (2021) (5)
- Prediction of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Using a Machine Learning Algorithm (2018) (5)
- Safety and efficacy of treatment with liposomal amphotericin B in elderly patients at least 65 years old with hematological diseases. (2016) (5)
- Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin (2017) (5)
- Alloreactive T Cells Display a Distinct Chemokine Profile in Response to Conditioning in Xenogeneic GVHD Models. (2019) (5)
- Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin (2017) (5)
- Chimerism induction and delayed onset of cytomegalovirus (CMV) infection after allogeneic reduced-intensity stem cell transplantation (RIST). (2002) (5)
- Effect of antithymocyte globulin on HLA-mismatched unrelated transplantation (2019) (5)
- Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. (2018) (5)
- Severe regimen-related toxicity occurring in a patient with XYY syndrome receiving allogeneic peripheral blood stem cell transplantation (2002) (5)
- The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDS (2017) (5)
- QUANTITATION OF HEPATITIS G VIRUS RNA IN ALLOGENEIC BONE MARROW TRANSPLANT RECIPIENTS (1998) (5)
- Late-onset pneumatosis cystoides intestinalis associated with non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation (2008) (5)
- Long-term results of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia: a retrospective analysis of 10-year follow-up data (2020) (5)
- Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma (2016) (5)
- Treatment of acute myeloid leukemia. (1999) (5)
- Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis (2016) (5)
- Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma (2007) (5)
- Risk factors for high-dose methotrexate-induced nephrotoxicity (2021) (5)
- Splenic Peliosis in a Patient with Aplastic Anemia during Danazol Therapy (2007) (5)
- Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2 (2022) (5)
- Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma (2016) (5)
- Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation (2019) (5)
- The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis (2013) (5)
- Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria (2020) (5)
- Clinical Impacts of Germline DDX41 Mutations on Myeloid Neoplasms (2020) (5)
- Delayed recovery of neutrophil counts after peripheral stem cell transplantation which improved with administration of a minimal dose of G-CSF: a case report. (2001) (5)
- Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis (2016) (5)
- TT Virus in Hematological Disorders and Bone Marrow Transplant Recipients (2001) (5)
- Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status (2021) (5)
- High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement (2017) (4)
- Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia (2016) (4)
- Influence of blood sampling sites on measurement of blood cyclosporine concentration. (2000) (4)
- Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases (2015) (4)
- The Relationship between Hospitalization and Patient-Reported Outcomes (PROs) in Patients with FLT3-Mutated (FLT3mut+) Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study (2019) (4)
- JSH guideline for tumors of hematopoietic and lymphoid tissues—leukemia: 3. Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL) (2017) (4)
- Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases (2015) (4)
- The Relationship between Transplant Status and Patient-Reported Outcomes in Patients with FLT3-Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study (2019) (4)
- Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome (2019) (4)
- Hematopoietic Stem Cell Transplantation From a Related Donor with Human Leukocyte Antigen 1-Antigen Mismatch in the Graft-Versus-Host Direction Using Low-dose Anti-thymocyte Globulin (2020) (4)
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies (2008) (4)
- Persistence of recipient‐derived as well as donor‐derived clones of cytomegalovirus pp65‐specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation (2014) (4)
- Decision analysis for donor selection in stem cell transplantation—HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor (2014) (4)
- NGS-Based Copy Number Analysis in 1,185 Patients with Myeloid Neoplasms (2016) (4)
- Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial. (2020) (4)
- Persistence of recipient‐derived as well as donor‐derived clones of cytomegalovirus pp65‐specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation (2014) (4)
- Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma (2018) (4)
- Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease (2019) (4)
- Hyperbilirubinemia in the early phase after allogeneic HSCT: prognostic significance of the alkaline phosphatase/total bilirubin ratio (2013) (4)
- Impact of genetic alterations in stem-cell transplantation for myelodysplasia and secondary acute myeloid leukemia Short title: Genetic alterations in myelodysplasia with HCT (2017) (4)
- A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: Reduced cyclophosphamide combined with etoposide and total body irradiation (2008) (4)
- Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. (2016) (4)
- Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index (2019) (4)
- Hyperbilirubinemia in the early phase after allogeneic HSCT: prognostic significance of the alkaline phosphatase/total bilirubin ratio (2013) (4)
- Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study (2021) (4)
- Subcellular localization of the MEN, MLL/MEN and truncated MLL proteins expressed in leukemic cells carrying the t(11;19)(q23;p13.1) translocation. (1997) (4)
- Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia. (2019) (4)
- Related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction and HLA 8/8-allele-matched unrelated transplantation: A nationwide retrospective study (2011) (4)
- Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography (2018) (4)
- Lack of Correlation Between Clinical Characteristics and Serum Soluble Fas Ligand Levels in Patients with Multiple Myeloma (2001) (4)
- The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch. (2003) (4)
- Intramural hematoma of stomach after splenectomy for idiopathic thrombocytopenic purpura. (1999) (4)
- Successful Bone Marrow Transplantation for Adult T-Cell Leukemia from a Donor with Oligoclonal Proliferation of T-Cells Infected with Human T-Cell Lymphotropic Virus (2001) (4)
- Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non‐remission acute myeloid leukaemia: A nationwide retrospective study (2022) (4)
- Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-matched Allogeneic Transplantation: A Japanese National Registry Study. (2019) (4)
- Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography (2018) (4)
- Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma (2019) (4)
- Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group (2022) (4)
- Allogeneic hematopoietic stem cell transplantation for primary and secondary myelofibrosis:a retrospective, multicenter study of the Kanto Study Group for Cell Therapy (KSGCT) (2012) (3)
- Steep neutrophil recovery following unrelated bone marrow transplantation is a major risk factor for the development of acute graft‐vs‐host disease—a retrospective study (2020) (3)
- Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (2017) (3)
- Salvage Chemotherapy Followed by Autologous Stem-Cell Transplantation Using Targeted Busulfan for Refractory Diffuse Large B-Cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease. (2019) (3)
- HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome (2018) (3)
- Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia (2014) (3)
- Preservation of fertility in patients with hematological malignancies. (2020) (3)
- Outcomes of allogeneic hematopoietic stem cell transplantation for ATL with HTLV-1 antibody positive donors: Allo-HCT for ATL from HTLV-1 antibody positive donors. (2019) (3)
- Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis (2021) (3)
- Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose (2022) (3)
- Comparison of the antigenemia assay and screening bronchoscopy for detection of cytomegalovirus infection after bone marrow transplantation (1999) (3)
- The Impact of Donor Age on Outcome after Unrelated Bone Marrow Transplantation: Comparison with Unrelated Cord Blood Transplantation (2015) (3)
- Role of Genetic Polymorphism of ALDH2 in Hematopoietic Stem Cell Transplantation. (2017) (3)
- Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia After an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Tran (2020) (3)
- Haemopoietic stem-cell transplantation for juvenile chronic arthritis (1999) (3)
- Prediction of infectious events by the high‐sensitivity C‐reactive protein level before autologous hematopoietic cell transplantation for lymphoma and multiple myeloma (2013) (3)
- Impact of neutropenia evaluated in terms of the D‐index on invasive fungal disease while on empiric or preemptive antifungal treatment strategy in the early phase after allogeneic hematopoietic stem cell transplantation (2020) (3)
- Dosimetric evaluation of ovaries and pelvic bones associated with clinical outcomes in patients receiving total body irradiation with ovarian shielding (2021) (3)
- Post-transplant endothelial disorder after hematopoietic SCT: a blinded autopsy study (2012) (3)
- Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II–IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group (2021) (3)
- Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation (2009) (3)
- Prospective validation of the L-index reflecting both the intensity and duration of lymphopenia and its detailed evaluation using a lymphocyte subset analysis after allogeneic hematopoietic stem cell transplantation. (2019) (3)
- Prediction of CMV reactivation by recipient CMV-IgG titer before allo-HCT. (2021) (3)
- Impact of Somatic Mutations on Outcome in Patients with MDS after Stem-Cell Transplantation (2015) (3)
- Immunity and Vaccination Against Measles, Mumps, and Rubella in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients. (2021) (3)
- Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning (2015) (3)
- Risks and benefits of ovarian shielding in female patients undergoing TBI: a decision analysis (2011) (3)
- Detection of active human cytomegalovirus by the promyelocytic leukemia body assay in cultures of PBMCs from patients undergoing hematopoietic stem cell transplantation (2012) (3)
- Graft-versus-host disease prophylaxis using low-dose antithymocyte globulin in peripheral blood stem cell transplantation - A matched-pair analysis. (2021) (3)
- Immunity and Vaccination Against Measles, Mumps, and Rubella in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients. (2021) (3)
- Prospective validation of the L-index reflecting both the intensity and duration of lymphopenia and its detailed evaluation using a lymphocyte subset analysis after allogeneic hematopoietic stem cell transplantation. (2019) (3)
- Hematopoietic Cell Transplantation for Acute Panmyelosis with Myelofibrosis: A Retrospective Study in Japan. (2019) (3)
- Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2. (2021) (3)
- Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia (2021) (3)
- GVHD after HLA-matched sibling BMT or PBSCT: Comparison of North American Caucasian and Japanese Populations (2016) (3)
- Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning (2015) (3)
- Impact of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect Based on Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (2019) (3)
- Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study (2021) (3)
- Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia (2021) (3)
- Voriconazole Vs. Itraconazole for Antifungal Prophylaxis in Patients with GVHD: A Randomized Trial (2014) (3)
- Body Weight Loss Before Allogeneic Hematopoietic Stem Cell Transplantation Predicts Survival Outcomes in Acute Leukemia Patients. (2021) (3)
- Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia (2014) (3)
- PCN485 PATIENT-REPORTED OUTCOMES AND THEIR RELATIONSHIP WITH CLINICAL OUTCOMES IN PATIENTS WITH FLT3-MUTATED (FLT3MUT+) RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE PHASE 3 ADMIRAL STUDY (2019) (3)
- Non-infectious bronchiolitis as an early pulmonary complication of hematopoietic stem cell transplantation. (2008) (3)
- Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT (2019) (3)
- Persistent infection with human T lymphotropic virus type 1 after allogeneic bone marrow transplantation from a seronegative donor (1999) (3)
- Outcomes and prognostic factors for patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter analysis. (2020) (3)
- Etoposide with/without G‐CSF with busulfan and cyclophosphamide as conditioning for bone marrow transplantation (1996) (3)
- Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study (2018) (3)
- Prediction of infectious events by the high‐sensitivity C‐reactive protein level before autologous hematopoietic cell transplantation for lymphoma and multiple myeloma (2013) (3)
- T-cell leukemia cells . expression of the interleukin-5 gene in adult protein , and AP-1 is required for constitutive virus type 1-encoded tax , GATA-binding Triple synergism of human T-lymphotropic (1997) (3)
- Sustained molecular remission in a patient with CML in blastic crisis receiving dose‐reduced hematopoietic stem‐cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon‐α (2002) (2)
- Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation. (2013) (2)
- Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease (2020) (2)
- Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation (2022) (2)
- Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT) (2018) (2)
- A leukemic double-hit follicular lymphoma associated with a complex variant translocation, t(8;14;18)(q24;q32;q21), involving BCL2, MYC, and IGH. (2018) (2)
- Surgical resection for persistent localized pulmonary fungal infection prior to allogeneic hematopoietic stem cell transplantation: Analysis of six cases. (2019) (2)
- Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma (2020) (2)
- Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation (2022) (2)
- Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models. (2021) (2)
- Clinical course of patients with aplastic anemia or myelodysplastic syndrome associated with persistent neutropenia (2012) (2)
- The effect of graft‐versus‐host disease on outcomes after allogeneic stem cell transplantation for refractory lymphoblastic lymphoma in children and young adults (2019) (2)
- Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT. (2019) (2)
- Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation (2018) (2)
- Effect of allogeneic stem cell transplantation in patients with minimally differentiated acute myeloid leukemia (2019) (2)
- The prognostic significance of rapid peripheral blood blast clearance during the initial course of induction chemotherapy in young patients with de novo acute myeloid leukemia (2017) (2)
- Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan (2018) (2)
- Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors. (2017) (2)
- Prognostic Impact of the Fractionation of Total Body Irradiation for Patients with Acute Myeloid Leukemia Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation. (2021) (2)
- Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan (2018) (2)
- Standard practice of the physical therapy for patients who underwent allogeneic hematopoietic stem cell transplantation (2018) (2)
- Efficacy and Safety of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma in the Era of Novel Agents (2018) (2)
- Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study (2022) (2)
- Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (2021) (2)
- Surgical resection for persistent localized pulmonary fungal infection prior to allogeneic hematopoietic stem cell transplantation: Analysis of six cases. (2019) (2)
- Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation (2018) (2)
- Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation (2022) (2)
- Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy‐refractory or relapsed disease prior to allogeneic stem cell transplantation (2021) (2)
- Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation. (2013) (2)
- Successful HLA-haploidentical stem cell transplantation with post-transplant cyclophosphamide in an older patient with chronic active Epstein–Barr virus infection (2022) (2)
- Safety and Risk of Allogeneic Peripheral Blood Stem Cell Donation: The Comprehensive Report of Nation-Wide Consecutively Pre-Registered 3,264 Family Donor Survey In 10years Project by Japan Society for Hematopoietic Cell Transplantation. (2010) (2)
- Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant (2019) (2)
- Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial (2021) (2)
- Impact of the patient's body weight on the efficacy and adverse events of valganciclovir for cytomegalovirus reactivation after hematopoietic stem cell transplantation (2020) (2)
- Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy (2019) (2)
- [Early blastic transformation within a year of imatinib treatment in 2 cases of chronic myeloid leukemia]. (2007) (2)
- Characterization of acute graft‐versus‐host disease following reduced‐intensity stem‐cell transplantation from an HLA‐identical related donor (2008) (2)
- Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation (2018) (2)
- Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation (2020) (2)
- Allogeneic Hematopoietic Stem Cell Transplantation as a Promising Treatment for Natural Killer-Cell Neoplasms. (2004) (2)
- Mesenchymal Stromal Cells Inhibit Aerobic Glycolysis in Activated T Cells by Negatively Regulating Hexokinase II Activity Through PD-1/PD-L1 Interaction. (2021) (2)
- Multiple myeloma derived from a kidney transplant donor who also developed myeloma after kidney donation (2019) (2)
- Retrospective analysis of autologous stem cell transplantation for AL amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation. (2021) (2)
- A limitation of fluorescence in situ hybridization (FISH) assays targeting sex chromosomes for monitoring of early relapse after transplantation. (2001) (2)
- Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation (2021) (2)
- Haploidentical transplantation with post‐transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: A retrospective study from the Adult Myelodysplastic Syndrome Working Group of the Japanese Society for Transplantation and Cellular Therapy (JSTCT) (2022) (2)
- Is pharmacokinetic guidance a must in busulfan regimens? (2018) (2)
- Risk Factors for Complications Associated with Peripherally Inserted Central Catheters During Induction Chemotherapy for Acute Myeloid Leukemia (2021) (2)
- Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease (2021) (2)
- [Lymphoid malignancies: progress in diagnosis and treatment. Topics: III. Diagnosis and treatment: 4. Role of hematopoietic stem cell transplantation in the treatment of lymphoid malignancies]. (2011) (2)
- Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors (2021) (2)
- Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT. (2019) (2)
- Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis (2020) (2)
- Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study) (2018) (2)
- Impact of the patient's body weight on the efficacy and adverse events of valganciclovir for cytomegalovirus reactivation after hematopoietic stem cell transplantation (2020) (2)
- Long-term third chronic phase of chronic myelogenous leukemia maintained by interferon-alpha and methotrexate. (1999) (2)
- Effect of multiple HLA-locus mismatches on outcomes after single cord blood transplantation. (2022) (2)
- Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors. (2017) (2)
- Efficacy and Safety of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma in the Era of Novel Agents (2018) (2)
- Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors (2021) (2)
- Coronary Artery-Coronary Sinus Fistulae Associated with a Large Hepatic Hemangioma (1995) (2)
- Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation (2018) (2)
- TAFRO Syndrome with an Anterior Mediastinal Mass and Lethal Autoantibody-Mediated Thrombocytopenia: An Autopsy Case Report (2019) (2)
- Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation (2018) (2)
- Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation (2021) (1)
- Guest Editorial: Retrospective cohort studies using the registry database of hematopoietic stem cell transplantation in Japan. How can we produce reliable Japanese evidences? (2015) (1)
- Myeloablative versus reduced-intensity conditioning with fludarabine/busulfan for myelodysplastic syndrome: A propensity score-matched analysis. (2022) (1)
- Rapid progression of chronic myelomonocytic leukemia following diaminodiphenyl sulphone treatment for dermatitis herpetiformis. (1997) (1)
- Impact of high frequency HLA haplotypes on clinical cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation. (2019) (1)
- Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older (2016) (1)
- A consideration for efficient unrelated hematopoietic stem cell source acquisition—from an experience of Japan (2019) (1)
- Pre-Hematopoietic Stem Cell Transplantation Lung Computed Tomography as an Alternative to the Pulmonary Function Test during the COVID-19 Pandemic (2020) (1)
- Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation (2021) (1)
- Radiation Myelopathy Caused by Palliative Radiotherapy and Intrathecal Methotrexate (2022) (1)
- Mixed Chimerism and Secondary Engraftment Failure in Allogeneic Transplantation for Aplastic Anemia (2018) (1)
- Dosimetric Evaluation of the Uterus in Patients Receiving Total Body Irradiation with Ovarian Shielding (2022) (1)
- A Markov Decision Analysis of Post-Remission Strategies in 2029 Patients with AML in First Remission (CR1): Should We Perform Allogeneic Hematopoietic Cell Transplantation in CR1?. (2009) (1)
- Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation (2021) (1)
- [Allogeneic hematopoietic stem cell transplantation for solid tumors]. (2004) (1)
- Comparison of reduced-intensity/toxicity conditioning regimens for umbilical cord blood transplantation for lymphoid malignancies (2020) (1)
- Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation (2022) (1)
- Anti-thymocyte globulin could potentially overcome an adverse effect of acute GVHD in matched-related PBSCT (2021) (1)
- Pseudo-autologous stem cell transplantation for donor-derived mantle cell lymphoma 12 years after allogeneic transplantation (2017) (1)
- Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia (2017) (1)
- Increased Mac 2-Binding Protein Glycan Isomer (M2BPGi) Would Predict Late Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation (2018) (1)
- Novel and Significant Impact of Germline Variants Predisposed to Pathogenic Somatic Mutations and Loss of Heterozygosity (LOH) in Myelodysplastic Syndromes (MDS) and Clonal Hematopoiesis of Indeterminate Potential (CHIP) (2018) (1)
- Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation (2022) (1)
- A Decision Analysis of Unrelated Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia In First Remission Who Lack An HLA-Matched Sibling (2010) (1)
- The Outcomes Of Allogeneic Stem Cell Transplantation In Patients With Mixed Phenotype Acute Leukemia (MPAL) Are Comparable To Those In Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL): Results Of a Matched-Pair Analysis (2013) (1)
- Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older (2016) (1)
- Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab (2020) (1)
- Prognostic Impact of Cytogenetic Abnormalities in Adult Patients with Philadelphia-Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Who Underwent Allogeneic Stem Cell Transplant (allo-SCT) (2015) (1)
- Could the minimum number of haematopoietic stem cells to obtain engraftment exist in unrelated, single cord blood transplantation? (2020) (1)
- Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non‐relapse mortality after allogeneic hematopoietic stem cell transplantation (2021) (1)
- Allogeneic hematopoietic cell transplantation for patients with relapsed acute promyelocytic leukemia. (2022) (1)
- Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan (2018) (1)
- Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation (2021) (1)
- Autologous Hematopoietic Recovery after Unrelated Umbilical Cord Blood Transplantation with Myeloablative Conditioning for Acute Myelogenous Leukemia (2020) (1)
- Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis. (2018) (1)
- Two granulocytic regions in bone marrow with eosinophilia evaluated by flow cytometry. (2014) (1)
- The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study (2015) (1)
- Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis (2021) (1)
- Wide availability of HLA‐matched or a few loci‐mismatched donors in the graft‐vs‐host direction among nonsibling first‐degree relatives (2020) (1)
- Skewed Repertoire Reconstitution and Gene Expression of HLA-A2402 CMV-CTLs after Allogeneic HCT (2020) (1)
- Increased Mac 2-Binding Protein Glycan Isomer (M2BPGi) Would Predict Late Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation (2018) (1)
- Risk and predictive factors for candidemia after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group (2022) (1)
- HSV-2 (2020) (1)
- Low-intensity immunosuppressive therapy for chronic graft-versus-host disease. (2022) (1)
- Novel indicators of transplant outcomes for PhALL: "current molecular-relapse-free survival". (2021) (1)
- Impact of blood pressure early after allogeneic hematopoietic cell transplantation on clinical outcomes (2020) (1)
- [Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation]. (2007) (1)
- Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis (2021) (1)
- Increased CD83 expression of CD34-positive monocytes in donors during peripheral blood stem cell mobilization in humans (2019) (1)
- Intensified conditioning regimens improved disease‐free survival and engraftment after unrelated single‐unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation (2022) (1)
- Recurrent Enteritis Associated with Epstein-Barr Virus-positive CD4+ T-cell Lymphoproliferative Disorder after Autologous Stem Cell Transplantation (2020) (1)
- Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. (2022) (1)
- [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL]. (2015) (1)
- [Chronic myelogenous leukemia in cessation of therapy after sustained CCR with interferon]. (2003) (1)
- Pre-transplant red blood cell and platelet transfusion burden in de novo myelodysplastic syndrome undergoing allogeneic transplantation: Pre-transplant red blood cell and platelet transfusion burden in de novo MDS after allogeneic transplantation. (2021) (1)
- Guest editorial: role of monoclonal antibodies for the prevention and treatment of graft-versus-host disease (2011) (1)
- Allogeneic hematopoietic stem cell transplantation for adult Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in second complete remission. (2022) (1)
- Autologous Hematopoietic Recovery after Unrelated Umbilical Cord Blood Transplantation with Myeloablative Conditioning for Acute Myelogenous Leukemia (2020) (1)
- The Safety of Hematopoietic Stem Cell Harvest from Elderly Family Donor in Japan (2015) (1)
- Increased CD83 expression of CD34-positive monocytes in donors during peripheral blood stem cell mobilization in humans (2019) (1)
- Association between Activated Partial Thromboplastin Time and the Amount of Infused Heparin at Bone Marrow Transplantation. (2018) (1)
- Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement". (2020) (1)
- Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT (2020) (1)
- Allotype analysis to determine the origin of cytomegalovirus immunoglobulin‐G after allogeneic stem cell transplantation (2014) (1)
- Unrelated Donor Marrow Transplantation for Acute Lymphoblastic Leukemia in Japan. A Japan Marrow Donor Program Experience between 1993 and 2003. (2005) (1)
- Association between Activated Partial Thromboplastin Time and the Amount of Infused Heparin at Bone Marrow Transplantation. (2018) (1)
- Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study (2020) (1)
- Impact of blood pressure early after allogeneic hematopoietic cell transplantation on clinical outcomes (2020) (1)
- B loodstream Infection after Umbilical Cord Blood ransplantation Using Reduced-Intensity Stem Cell ransplantation for Adult Patients (2005) (1)
- Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program (2022) (1)
- Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation (2022) (1)
- Risk Factors and Predictive Scoring System for Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation (2018) (1)
- Urine Xanthine Crystals in Hematologic Malignancies with Tumor Lysis Syndrome (2022) (1)
- Comparison of reduced-intensity/toxicity conditioning regimens for umbilical cord blood transplantation for lymphoid malignancies (2020) (1)
- Skewed Repertoire Reconstitution and Gene Expression of HLA-A2402 CMV-CTLs after Allogeneic HCT (2020) (1)
- Relapsed and refractory multiple myeloma: A systematic review and network meta‐analysis of the efficacy of novel therapies (2023) (1)
- Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma. (2016) (1)
- Neutropenia in the First Cycle of Consolidation Chemotherapy with High-Dose Cytarabine Is Not Associated with the Incidence of Relapse in Adult Acute Myeloid Leukemia Patients in First Complete Remission (2022) (1)
- Comparison of immune recovery after allogeneic PBSCT between reduced-intensity transplant with or without antithymocyte globulin and conventional transplant (2001) (1)
- Allotype analysis to determine the origin of cytomegalovirus immunoglobulin‐G after allogeneic stem cell transplantation (2014) (1)
- Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood Transplantation. (2022) (1)
- NILOTINIB SHOWS SUSTAINED BENEFIT COMPARED WITH IMATINIB IN PATIENTS (PTS) WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): ENESTND 4-YEAR FOLLOW-UP (F/U) (2013) (1)
- Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors (2022) (1)
- Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma (2022) (1)
- Differential Localization and Invasion of Tumor Cells in Mouse Models of Human and Murine Leukemias (2020) (1)
- Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adult Patients with Acute Myeloid Leukemia. (2021) (1)
- Fungal biomarker monitoring and CT scans for early detection of invasive fungal disease in neutropenic hematological patients. (2021) (1)
- Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma. (2016) (1)
- Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre‐transplant conditioning using fludarabine, reduced‐dose cyclophosphamide, and low‐dose thymoglobulin: A KSGCT prospective study (2019) (1)
- Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adult Patients with Acute Myeloid Leukemia. (2021) (1)
- Pseudo-autologous stem cell transplantation for donor-derived mantle cell lymphoma 12 years after allogeneic transplantation (2017) (1)
- Antileukemic immunity associated with antineutrophil antibody production after allogeneic hematopoietic SCT for myeloid/NK-cell precursor acute leukemia (2008) (1)
- The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin (2019) (1)
- Study of twice marrow donations from unrelated donors in Japan Marrow Donor Program (2017) (1)
- Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis (2019) (1)
- Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia (2017) (1)
- Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT (2018) (1)
- Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia (2017) (1)
- B ffect of Conditioning Regimen on the Outcome of one Marrow Transplantation from an Unrelated onor (2005) (0)
- Steep Neutrophil Recovery Following Unrelated Bone Marrow Transplantation Is a Major Risk Factor for the Development of Acute Graft-Vs-Host Disease (2019) (0)
- Prophylactic Use of Tyrosine Kinase Inhibitors in Patients with Negative Results for Minimal Residual Disease after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (2019) (0)
- Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors (2020) (0)
- ネットワークメタアナリシス (2020) (0)
- Difference in the Donor Selection Priority in Allogeneic Hematopoietic Stem Cell Transplantation According to Patient Age. (2019) (0)
- [Hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia]. (2010) (0)
- Impact of Human Leukocyte Antigen Epitope Matching on Outcomes after Unrelated Bone Marrow Transplantation (2021) (0)
- Comparison Between Busulfan with Cyclophosphamide and Busulfan with Fludarabine As Myeloablative Conditioning of Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies (2016) (0)
- Impact of a low CD34 dose on allogeneic peripheral blood stem cell transplantation Running title: Low CD34 in allogeneic PBSCT (2017) (0)
- 9. Current Treatment and Future Prospects of Malignant Lymphoma. (2010) (0)
- Alloantigen-Activated Human T-Cells Increase Extracellular Fatty Acid Uptake and Intracellular Lipid Metabolism during Xenogeneic Gvhd (2018) (0)
- POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN PATIENTS WITH LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (2019) (0)
- PS1277 EVALUATION OF THE IMMUNITY TO MEASLES, MUMPS AND RUBELLA IN ADULT PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (2019) (0)
- Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers (2022) (0)
- [Mini-transplantation using non-myeloablative or reduced-intensity conditioning regimen]. (2007) (0)
- Central Nervous System Invasion in Multiple Myeloma: A Nationwide Survey of 75 Patients in Japan (2016) (0)
- [Management of viral infection in patients with hematological malignancies]. (2012) (0)
- Vitamin K2 (VK2) Monotherapy and VK2 Plus D3 Combination Therapy in Low-Risk Myelodysplastic Syndrome: A Prospective Japanese Study. (2005) (0)
- [Fertility preservation in patients with hematological malignancies]. (2015) (0)
- Improvement of Early Mortality in Single-Unit Cord Blood Transplantation for Adults During 20 Years: A Retrospective Cohort Study (2019) (0)
- Detailed Assessment of Blood Culture and Clinical Factors in Febrile Neutropenia Patients with High-Risk Hematological Malignancy in Japan: A Subgroup Analysis of the Cedmic Trial (2020) (0)
- Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents (2022) (0)
- Prognostic impact of complex karyotype on post‐transplant outcomes of myelofibrosis (2022) (0)
- Author response for "Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation" (2019) (0)
- Impact of Parental Donor Type On Outcomes After HLA-Matched and HLA-Mismatched T-Cell-Replete Hematopoietic Cell Transplantation for Patients with Leukemia: A Retrospective Cohort Study. (2012) (0)
- Influence of HLA 1–3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation (2020) (0)
- Thanking All Peer Reviewers. (2015) (0)
- Development of a Prognostic Scoring System using MYC Expression and Soluble Interleukin Receptor -2 level for Diffuse Large B-cell Lymphoma. (2023) (0)
- Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation. (2022) (0)
- [Chemotherapy and hematopoietic stem cell transplantation for acute lymphoblastic leukemia]. (2012) (0)
- Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors (2022) (0)
- Chronic active Epstein-Bar virus infection complicated by pulmonary artery hypertension. (2022) (0)
- Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group (2018) (0)
- Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia (2022) (0)
- S1639 SAFETY AND EFFICACY OF LIVE ATTENUATED VARICELLA VACCINE FOR PREVENTING VARICELLA ZOSTER VIRUS DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PROSPECTIVE SINGLE-CENTER STUDY (2019) (0)
- Integrated Analysis of Copy-Number Alterations and Gene Mutations in 2,000 Patients with Myeloid Neoplasms (2019) (0)
- Judgmental criteria by physical therapists for the patients receiving allogeneic hematopoietic stem cell transplantation in Japan (2015) (0)
- Influence of HLA 1–3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation (2020) (0)
- Marrow Transplantation Cytomegalovirus Infection after Bone Diagnosis and Monitoring of Real-Time Automated PCR for Early (2000) (0)
- O-70 Vitamin K2 therapy in low-riskmyelodysplastic syndrome: A prospective Japanese study (2005) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Light Renal Failure (2011) (0)
- Comprehensive Analysis of Activation and Proliferation Kinetics and Effector Functions of Human Lymphocyte Subsets in Xenogeneic GvHD Model (2016) (0)
- 自立と共生の教育社会学(その2)地域民主主義と学校の再生 (2007) (0)
- Very early death within 30 days after diagnosis in patients with acute myeloid leukemia (2022) (0)
- Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A KSGCT Multicenter Analysis. (2023) (0)
- Reactivation of Cytomegalovirus Following Reduced-Intensity Cord Blood Transplantation for Adult Patients. (2005) (0)
- Pretransplantation Red Blood Cell and Platelet Transfusion Burden in De Novo Myelodysplastic Syndrome Undergoing Allogeneic Transplantation (2021) (0)
- Effect of graft-versus-host disease on posttransplant outcomes following single cord blood transplantation in comparison to haploidentical transplantation with posttransplant cyclophosphamide for adult acute myeloid leukemia. (2023) (0)
- Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan. (2022) (0)
- Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation (2023) (0)
- Effect of Cytomegalovirus Reactivation with or Without Acute GVHD on the Risk of Nonrelapse Mortality (2020) (0)
- Different effects of thymoglobulin on acute leukemia with pre-transplant residual blasts in HLA mismatch transplantation. (2023) (0)
- Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia (2023) (0)
- hest Computed Tomography of Late Invasive spergillosis after Allogeneic Hematopoietic Stem ell Transplantation (2012) (0)
- Educational Reform and the Learning Right of People (2001) (0)
- the Safety and Efficacy of Deferasirox for the Transplant Patients with Iron Overload (2016) (0)
- Identifying the optimal conditioning intensity for stem cell transplantation in patients with myelodysplastic syndrome: a machine learning analysis (2022) (0)
- [[The future directions of clinical hematology in 2013 - hematopoietic stem cell transplantation-overview]. (2013) (0)
- S1639 SAFETY AND EFFICACY OF LIVE ATTENUATED VARICELLA VACCINE FOR PREVENTING VARICELLA ZOSTER VIRUS DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PROSPECTIVE SINGLE-CENTER STUDY (2019) (0)
- Role of Anti-Lymphocyte Globulin in Prophylaxis of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation in Patients with Acute Leukemia (2018) (0)
- Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation (2022) (0)
- Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors (2020) (0)
- Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplant Outcomes?: A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy (KSGCT) (2012) (0)
- Forodesine Amplifies Host Innate Immune Response through Toll-like Receptor 7 Activation While Preventing Experimental Graft-Versus-Host Disease (2022) (0)
- Low-Dose Immunosuppressants for the Treatment of Chronic Graft-Versus-Host Disease (2021) (0)
- [Invasive fungal infection management in patients with hematological malignancies]. (2022) (0)
- Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model (2018) (0)
- Targeting Complete Response with Upfront Bortezomib Followed By Autologous Transplantation and Consolidation Therapy for Untreated Multiple Myeloma (TUBA study) (2016) (0)
- 自立と共生の教育社会学(その3)地域民主主義と学校の再生 (2008) (0)
- A Markov Decision Analysis Of Post-Remission Strategies In 2029 Patients With AML In First Remission (CR1) (2010) (0)
- Correction to: Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma (2018) (0)
- Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series (2022) (0)
- Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan (2022) (0)
- Impact Of Systemic Antibiotic Prophylaxis In Hematopoietic Stem Cell Transplantation Recipients. A Meta-Analysis Of Randomized Controlled Trials (2013) (0)
- Chronic active Epstein-Bar virus infection complicated by pulmonary artery hypertension. (2022) (0)
- FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame (2012) (0)
- Author response for "Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation" (2019) (0)
- Abstract 2282: Smoking and alcohol and the risk of myelodysplastic syndrome: The JPHC study (2017) (0)
- PS1277 EVALUATION OF THE IMMUNITY TO MEASLES, MUMPS AND RUBELLA IN ADULT PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (2019) (0)
- NAUSEA AND ANOREXIA DURING GRANULOCYTE COLONY-STIMULATING FACTOR ADMINISTRATION FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION (2015) (0)
- Pre-HCT lung computed tomography as an alternative to PFT during the COVID-19 Pandemic (2020) (0)
- Frequent but Reversible and Manageable Cardiac Complications after Successful Haploidentical HLA-Mismatched Hematopoietic Stem Cell Transplantation (HSCT) without Ex Vivo Graft Manipulation. (2004) (0)
- D-index-guided early antifungal therapy for persistent FN in patients with hematological malignancies (CEDMIC trial) (2019) (0)
- Reduced Cyclophosphamide Combined with Etoposide and Total Body Irradiation as a Conditioning Regimen for Patients with Impaired Cardiac Function Undergoing Allogeneic Stem Cell Transplantation. (2007) (0)
- [Present status in hematopoietic stem cell transplantation (discussion)]. (2005) (0)
- HAEMOPOLETIC STEM-CELL TRANSPLANTATION FOR JUVENLLE CHRONIC ARTHRITIS. AUTHORS' REPLY (1999) (0)
- Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Myeloablative Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT) (2020) (0)
- Novel risk assessment for the intensity of conditioning regimen in elderly patients. (2022) (0)
- Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan (2022) (0)
- The Expression of CD83 Would be Increased in CD34-Positive Monocytes Detected in Peripheral Blood Mobilized By G-CSF in Humans (2018) (0)
- Pain and Opioid Use in Patients with FLT3 Mutation-Positive Relapsed/Refractory AML: A Subanalysis of Patient-Reported Outcomes from the Admiral Trial (2020) (0)
- Relationships Between Late Viral Infections and Immune Reconstitution after Hematopoietic Stem Cell Transplantation. (2008) (0)
- Correction to: Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2 (2022) (0)
- Myeloablative Vs Reduced-Intensity Conditioning for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Among Patients over 50 Years Old Who Achieved Negative Minimal Residual Disease (2020) (0)
- Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (2021) (0)
- Survival Outcomes of Allogeneic Transplantation in Heavy Smokers. (2020) (0)
- Creation of local universiy and the mission of Research and Education Center for Lifelong Learning (2004) (0)
- Would Bone Marrow be Associated with Superior Outcomes Compared with Peripheral Blood for Male Recipients with Female Donors in HLA-Matched Related Transplantation? (2018) (0)
- Effects of Eculizumab Treatment on the Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated in Japan (2017) (0)
- Persistent Expression of Recipient-type ABH Antigen after ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation (2021) (0)
- Severe Adverse Events of Allogeneic Related Peripheral Blood Stem Cell Donors -Results of Nation-Wide 3,262 Consecutively and Prospectively Registered Case-Survey in Japan and of Its Comparison to the Outcome of Retrospective Survey Shared with EBMT for Stem Cell Donors. (2005) (0)
- Empiric or Presumptive Anti-Aspergillus Treatments for Allogeneic Hematopoietic Stem Cell Transplant Recipients with Sustained Febrile Neutropenia. (2006) (0)
- [Graft-versus-host disease: friend or foe?]. (2008) (0)
- Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Japan (2019) (0)
- Renal dysfunction after allogeneic stem cell transplantation: Risk factors and outcome (2006) (0)
- New farm village construction and Community Learning center of Nam Dinh in northern Vietnam (2015) (0)
- [Successful outcome of allogeneic hematopoietic stem cell transplantation for systemic mastocytosis complicated with acute myeloid leukemia]. (2022) (0)
- Hepatic Niche Leads to Aggressive Natural Killer Cell Leukemia Proliferation (2021) (0)
- Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan (2021) (0)
- Clinical Significance of Mutations and Copy Number Lesions on Prognosis of Patients with MDS after Unrelated Bone Marrow Transplantation (2016) (0)
- Impact of the Presence of HLA 1-Locus Mismatch and the Use of Thymoglobulin in Unrelated Bone Marrow Transplantation (2016) (0)
- [Management of fungal infection in hematopoietic stem cell transplantation recipients]. (2008) (0)
- Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients. (2022) (0)
- Allogeneic Stem Cell Transplantation Conditioned with Myeloablative Regimens Containing Total Body Irradiation in Adolescent and Young Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Who Were Treated with Pediatric-Type Chemotherapy (2021) (0)
- Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT (2022) (0)
- International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation (2022) (0)
- II. Treatment of Acute Myeloid Leukemia (2018) (0)
- epatic Injury following Reduced Intensity Unrelated ord Blood Transplantation for Adult Patients ith Hematological Diseases (2006) (0)
- Virus in Bone Marrow Transplant Recipients (1999) (0)
- [Overview]. (2019) (0)
- O1-20-6DEVELOPMENT AND EVALUATION OF AN INDEX THAT PREDICTS PULMONARY FUNGAL INFECTION IN PATIENTS WITH FEBRILE NEUTROPENIA (2014) (0)
- Prognostic impact of chromosomal changes at relapse after allogeneic hematopoietic cell transplantation for acute myeloid leukemia or myelodysplastic syndrome (2022) (0)
- Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group. (2022) (0)
- Current status of HLA-mismatched related hematopoietic stem cell transplantation in Japan (2012) (0)
- Influence of psychosocial factors on mood states in adult patients shortly after hematopoietic stem cell transplantation (2003) (0)
- Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation: a Matched-Pair Analysis (2022) (0)
- Long-Term Persistence of Limited HTLV-I Tax-specific Cytotoxic T Cell Clones in a Patient with Adult T Cell Leukemia/Lymphoma after Allogeneic Stem Cell Transplantation (2012) (0)
- [Hematopoietic stem cell transplantation for adult acute myeloblastic leukemia]. (2011) (0)
- [Clinical safety data management in company non-sponsored trials]. (2003) (0)
- Effect of smoking on outcomes of allogeneic transplantation: a single center analysis. (2020) (0)
- 自立と共生の教育社会学(その4)地域民主主義と学校の再生 (2009) (0)
- [Non-myeloablative/reduced-intensity hematopoietic stem cell transplantation for chronic myelogenous leukemia]. (2001) (0)
- Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Hepatitis-Associated Aplastic Anemia (2017) (0)
- CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia. (2023) (0)
- 自立と共生の教育社会学(その8)学校におけるいじめ問題を中心に (2014) (0)
- The Effects of Indomethacin Spray on the Pain of Stomatitis in the Patients for Hematopoietic Stem Cell Transplantation (2004) (0)
- Clinical Significance of Wt1 mRNA Levels in Japanese Acute Lymphoblastic Leukemia Patients (2017) (0)
- Allogeneic hematopoietic stem cell transplantation for primary and secondary myelofibrosis (2012) (0)
- Viral infection Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation (2001) (0)
- Unrelated Bone Marrow Transplantation for Adult T Cell Leukemia/Lymphoma: A Study from the Japan Marrow Donor Program. (2005) (0)
- Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML (2020) (0)
- Reducing mortality of single-unit unrelated cord blood transplantation for relapsed acute myeloid leukemia after a previous allogeneic transplantation: a real-world retrospective study over the past 19 years in Japan. (2022) (0)
- Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma. (2023) (0)
- Case report Aspergillus tracheobronchitis after allogeneic bone marrow transplantation (1999) (0)
- Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT) (2022) (0)
- Relationship of tumor load parameters before and after autologous stem cell transplantation with clinical prognosis in transplant-eligible patients with multiple myeloma: a retrospective analysis (2021) (0)
- Outcome After First Relapse In Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (2011) (0)
- [Mini-transplant for acute myeloblastic leukemia and myelodysplastic syndrome]. (2003) (0)
- Body Weight Loss before Allogeneic Hematopoietic Stem Cell Transplantation Predicts Survival Outcomes in Acute Leukemia Patients (0)
- Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma (2023) (0)
- Use of Cyclosporine Is Associated with the Increase in Pre-Engraftment Syndrome After Myeloablative Dual Cord Blood Transplantation (2012) (0)
- Loss of Y-Chromosome before Allogeneic Hematopoietic Stem Cell Transplantation Influences on Relapse in Male Recipients with Female Donors (2022) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia (2020) (0)
- Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (2022) (0)
- Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes (2021) (0)
- International Collaborative Study to Compare the Prognosis for Acute Leukemia Patients Transplanted with Intensified Myeloablative Regimens (2022) (0)
- [Current clinical problems in non-myeloablative reduced-intensity hematopoietic stem cell transplantation]. (2002) (0)
- Erratum to "Detection of T315I using digital PCR in allogeneic transplant recipients with Ph-positive ALL in the dasatinib era": [Experimental Hematology 81 (2019) 60-67]. (2020) (0)
- Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the GVH Direction vs. HLA-8/8 Allele-Matched Unrelated Donor (2013) (0)
- Comparison of the incidence and organ distribution of acute graft-versus-host disease following allogeneic stem cell transplantation in japanese patients receiving bone marrow (BM) or peripheral blood stem cells (PBSC) (2000) (0)
- Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia (2023) (0)
- Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia (2018) (0)
- High-grade CMV antigenemia after hematopoietic stem cell transplantation Risk factor and outcome (2003) (0)
- The Novel Scoring System to Personalize the Conditioning Intensity in Elderly Patients (2022) (0)
- Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis (2023) (0)
- Impact of the Presence of HLA 1-Locus Mismatch and the Use of Thymoglobulin in Unrelated Bone Marrow Transplantation (2016) (0)
- Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1/FLT3-ITD Genotypes in Patients with Acute Myeloid Leukemia (2022) (0)
- Long-Term Persistence of Limited HTLV-I Tax-specific Cytotoxic T Cell Clones in a Patient with Adult T Cell Leukemia/Lymphoma after Allogeneic Stem Cell Transplantation (2012) (0)
- T-Cell Receptor Amino Acid Sequence Selected By Cytotoxic T Cells Specific to HTLV-1 in HLA-A02:01-Positive ATL Patients (2022) (0)
- 1018. Prevalence of Bacteremia/Fungemia and Pneumonia in Remission Induction Chemotherapy for Adult Acute Myeloid Leukemia From 1987 to 2005: Japan Adult Leukemia Study Group (JALSG) (2018) (0)
- Viral infections Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation (2002) (0)
- Persistent Expression of Recipient-type ABH Antigen after ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation (2021) (0)
- Clinical benefits of pre-conditioning intervention in patients with relapsed or refractory acute myeloid leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter analysis. (2020) (0)
- Allogeneic hematopoietic cell transplantation efficacy in patients with Philadelphia chromosome-positive acute myeloid leukemia in complete remission (2020) (0)
- Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases (2015) (0)
- Hematopoietic Stem Cell Transplantation (2020) (0)
- Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation (2021) (0)
- [Hematopoietic stem cell transplantation for multiple myeloma]. (2009) (0)
- A decision analysis for unrelated bone marrow transplantation or immediate cord blood transplantation for patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission: Unrelated BMT or immediate CBT for Ph-negative ALL. (2021) (0)
- Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia. (2023) (0)
- Efficacy of High-Dose Cytarabine Added to Cyclophosphamide/Total-Body Irradiation in the Conditioning Regimen of Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancy (2015) (0)
- The Safety and the Risk of Allogeneic Bone Marrow and Peripheral Blood Stem Cell Donation; Results of Nation-Wide Consecutive Pre-Transplant Registration of Related Donors in Japan. (2007) (0)
- Patient-reported outcomes from the phase 3 ADMIRAL trial in patients with FLT3-mutated relapsed/refractory AML. (2023) (0)
- Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation (2021) (0)
- Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia (2022) (0)
- Dimethyl Fumarate Ameliorates Graft-Versus-Host Disease By Negatively Regulating Aerobic Glycolysis in Alloreactive T-Cells (2020) (0)
- Impact Of Systemic Antibiotic Prophylaxis In Hematopoietic Stem Cell Transplantation Recipients. A Meta-Analysis Of Randomized Controlled Trials (2013) (0)
- Educational sociology for personality independence and humanity symbiosis : Modern poverty and the issue of development of the child (PART7) (2012) (0)
- [Significance of HLA 1-locus mismatch and ATG administration in unrelated hematopoietic stem cell transplantation]. (2018) (0)
- 49 Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis (HC) after hematopoietic stem cell transplantation (HSCT) (2003) (0)
- Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis (2022) (0)
- S135 NGS-BASED COPY-NUMBER ANALYSIS IN MORE THAN 2,000 PATIENTS WITH MYELOID NEOPLASMS (2019) (0)
- Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation (2022) (0)
- Ovarian shielding allows ovarian recovery and normal birth in female hematopoietic SCT recipients undergoing TBI (2008) (0)
- 農民運動と村落構造-上-長野県喬木村における部落有林野統一事業反対闘争を中心にして (1984) (0)
- [Haploidentical 2- or 3-antigen-mismatched hematopoietic stem cell transplantation using in vivo Campath-1H]. (2006) (0)
- Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1 (2022) (0)
- Incidence, Risk Factors and Outcomes of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation. (2006) (0)
- [Anti-MDA5 antibody-positive rapidly progressive interstitial lung disease after allogeneic hematopoietic cell transplantation successfully treated with triple immunosuppressive therapy]. (2023) (0)
- Reduced intensity regimen for a second mismatched transplant. (2001) (0)
- Salvage single-unit unrelated cord blood transplantation for graft failure following initial allogeneic transplantation in adult acute myeloid leukemia: trends in outcomes over the past 20 years (2022) (0)
- Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Japan (2019) (0)
- transplantation engraftment in adult patients receiving reduced-intensity cord blood Impact of HLA disparity in the graft-versus-host direction on (2013) (0)
- Hepatic Injury Following Reduced-Intensity Unrelated Cord Blood Transplantation for Adult Patients with Hematological Diseases. (2006) (0)
- PF781 FATTY ACID OXIDATION AND MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION REGULATE T-CELL EFFECTOR FUNCTION DURING GRAFT-VERSUS-HOST DISEASE (2019) (0)
- Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI (2022) (0)
- nvasive Fungal Infection Following Reduced-Intensity ord Blood Transplantation for Adult Patients with ematologic Diseases (2007) (0)
- Hayman, Laura L. (2019) (0)
- Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood (2022) (0)
- Corporate social responsibility and Local life : Kyocera CSR activity and Lecture by the local contribution of the Kokubu factory (2015) (0)
- Headaches: Psychological Management (2019) (0)
- Effect of smoking on outcomes of allogeneic transplantation: a single center analysis. (2020) (0)
- Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series (2023) (0)
- 自立と共生の教育社会学(その7)現代の貧困と子どもの発達問題 (2012) (0)
- [Efficiency of protective isolation in allogeneic stem cell transplantation in children]. (2002) (0)
- Feasibility of Reduced-Intensity Cord Blood Transplantation (RICBT) as a Salvage Therapy for Graft Failure (GF): Results of a Nationwide Survey of 63 Patients. (2006) (0)
- NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia (2022) (0)
- Similar Background of Graft-Versus-Host Disease (GVHD) Following Allogeneic Blood and Marrow Transplantation (Tx) in Korean and Japanese Populations Allows a Uniform Foundation To Perform Large-Scale Clinical Studies in the Region. (2007) (0)
- Difference in the Donor Selection Priority in Allogeneic Hematopoietic Stem Cell Transplantation According to Patient Age. (2019) (0)
- Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents (2019) (0)
- Author response for "Low incidence of post‐transplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab" (2019) (0)
- Erratum to "Detection of T315I using digital PCR in allogeneic transplant recipients with Ph-positive ALL in the dasatinib era": [Experimental Hematology 81 (2019) 60-67]. (2020) (0)
- Role of Chemotherapy before Allogeneic Stem Cell Transplantation (ALLO-SCT) from an HLA-Identical Sibling Donor for Myelodysplastic Syndrome (MDS). (2004) (0)
- PF784 COMPARISON OF ALEMTUZUMAB, ANTI-THYMOCYTE GLOBULIN AND POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE GRAFT-VS-HOST DISEASE AND GRAFT-VS-LEUKEMIA EFFECT IN XENOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (2019) (0)
- Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia (2022) (0)
- Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis (2023) (0)
- Dimethyl fumarate ameliorates graft‐versus‐host disease by inhibiting T‐cell metabolism and immune responses through a reactive oxygen species‐dependent mechanism (2022) (0)
- Additive Effects of Orthokeratology and Atropine 0.01% in Slowing Axial Elongation in Children with Myopia: First Year Results (2019) (0)
- Association Between Candidemia and Noninfectious Interstitial Pneumonia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group (2023) (0)
- Attenuate Graft-versus-Host Immunity Host-Residual Invariant NK T Cells (2005) (0)
- The Impact of HLA-Mismatch Direction on the Outcome of Unrelated Bone Marrow Transplantation: A Retrospective Analysis from the JSHCT HLA Working Group (2014) (0)
- The Expression of CD83 Would be Increased in CD34-Positive Monocytes Detected in Peripheral Blood Mobilized By G-CSF in Humans (2018) (0)
- Allogeneic hematopoietic cell transplantation efficacy in patients with Philadelphia chromosome-positive acute myeloid leukemia in complete remission (2020) (0)
- CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS TT Virus in Bone Marrow Transplant Recipients (2017) (0)
- Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases (2015) (0)
- Impact of HLA Mismatch on the Incidence of Acute GVHD and Rejection after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation (RICT). (2004) (0)
- Survival Outcomes of Allogeneic Transplantation in Heavy Smokers. (2020) (0)
- Thanking All Peer Reviewers. (2019) (0)
- COOMBS-NEGATIVE AUTOIMMUNE HEMOLYTIC ANEMIA ASSOCIATED WITH MYELODYSPLASTIC SYNDROME (2015) (0)
- Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents (2022) (0)
- Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation (2022) (0)
- Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Yoshinobu Kanda?
Yoshinobu Kanda is affiliated with the following schools:
